Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study

Ermis, O; Alpsoy, ERKAN; Cetin, L; Yilmaz, ERTAN

doi:10.1046/j.1365-2133.2001.04286.x

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study

Ermis O., Alpsoy E., Cetin L., Yilmaz E.

BRITISH JOURNAL OF DERMATOLOGY, cilt.145, sa.3, ss.472-475, 2001 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 145 Sayı: 3
Basım Tarihi: 2001
Doi Numarası: 10.1046/j.1365-2133.2001.04286.x
Dergi Adı: BRITISH JOURNAL OF DERMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.472-475
Anahtar Kelimeler: calcipotriol, psoralen plus ultraviolet A therapy, randomized controlled trial, vitiligo, CALCIUM, COMBINATION
Akdeniz Üniversitesi Adresli: Evet

Özet

Background Encouraging results of previous uncontrolled trials suggest that calcipotriol may potentiate the efficacy of psoralen plus ultraviolet (UV) A (PUVA) therapy in patients with vitiligo.